Ondansetron Compared with High-Dose Metoclopramide in Prophylaxis of Acute and Delayed Cisplatin-Induced Nausea and Vomiting - A Multicenter, Randomized, Double-Blind, Crossover Study

被引:274
作者
Demulder, PHM [1 ]
Seynaeve, C
Vermorken, JB
Vanliessum, PA
Molsjevdevic, S
Allman, EL
Beranek, P
Verweij, J
机构
[1] Univ Hosp Nijmegen, Dept Med, Div Med Oncol, POB 9101, NL-6500 HB Nijmegen, NETHERLANDS
[2] Free Univ Amsterdam Hosp, Amsterdam, NETHERLANDS
[3] Glaxo Grp Res Ltd, Greenford UB6 0HE, Middx, ENGLAND
[4] Rotterdam Canc Inst, Rotterdam, NETHERLANDS
[5] Maria Hosp, Tilburg, NETHERLANDS
关键词
D O I
10.7326/0003-4819-113-11-834
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Ondansetron is significantly more effective than metoclopramide in preventing acute nausea and vomiting. In the delayed phase, the results of both drugs were disappointing, although metoclopramide's effect on delayed nausea was superior. Patients preferred ondansetron.
引用
收藏
页码:834 / 840
页数:7
相关论文
共 45 条
  • [1] AGOSTINUCCI WA, 1986, CLIN PHARMACY, V5, P150
  • [2] ANTIEMETIC EFFECT OF ORAL VERSUS INTRAVENOUS METOCLOPRAMIDE IN PATIENTS RECEIVING CISPLATIN - A RANDOMIZED, DOUBLE-BLIND TRIAL
    ANTHONY, LB
    KROZELY, MG
    WOODWARD, NJ
    HAINSWORTH, JD
    HANDE, KR
    BRENNER, DE
    GRECO, FA
    BURISH, TG
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (01) : 98 - 103
  • [3] BRITTAIN R T, 1987, British Journal of Pharmacology, V90, p87P
  • [4] PHARMACOLOGICAL PROPERTIES OF GR38032F, A NOVEL ANTAGONIST AT 5-HT3 RECEPTORS
    BUTLER, A
    HILL, JM
    IRELAND, SJ
    JORDAN, CC
    TYERS, MB
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1988, 94 (02) : 397 - 412
  • [5] CLARK RA, 1989, P AN M AM SOC CLIN, V8, P330
  • [6] PREVENTION OF EMESIS IN PATIENTS RECEIVING CYTOTOXIC DRUGS BY GR38032F, A SELECTIVE 5-HT3 RECEPTOR ANTAGONIST
    CUNNINGHAM, D
    POPLE, A
    FORD, HT
    HAWTHORN, J
    GAZET, JC
    CHALLONER, T
    COOMBES, RC
    [J]. LANCET, 1987, 1 (8548) : 1461 - 1463
  • [7] THE EFFICACY OF GR38032F, AN ANTAGONIST OF 5-HYDROXYTRYPTAMINE-3 (5-HT3) IN THE PROPHYLAXIS OF CISPLATIN (CDDP)-INDUCED NAUSEA AND VOMITING
    DEHAAN, LD
    DEMULDER, PHM
    BEEX, LVAM
    DEBRUYNE, FMJ
    CHALLONER, T
    DEPAUW, BE
    [J]. EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1988, 24 (08): : 1383 - 1384
  • [8] FETTING JH, 1983, CANCER TREAT REP, V67, P1093
  • [9] NEURONAL 5-HT RECEPTORS IN THE PERIPHERY
    FOZARD, JR
    [J]. NEUROPHARMACOLOGY, 1984, 23 : 1473 - 1486
  • [10] GORDON CJ, 1989, CANCER, V63, P578, DOI 10.1002/1097-0142(19890201)63:3<578::AID-CNCR2820630330>3.0.CO